In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD, telmisartan upregulated the expression of BDNF and GDNF and reduced markers of inflammation such as TNF-α and IL-1 [106, 107]. This evidence concerns the gene GDNF and Parkinson disease.